DermaSensor Raises $16M in Series B

DermaSensor has successfully raised $16M in a Series B at a $85M valuation led by Healthtech Capital, LSP.

Company Overview

DermaSensor is a HealthTech company headquartered in Miami, FL, founded in 2020 with 70+ employees.

AI-powered skin cancer screening device for early detection

Fundraising Details

• Amount Raised: $16M
• Round Type: Series B
• Valuation: $85M
• Date: 2025-10-06
• Investors: Healthtech Capital, LSP

About DermaSensor

AI-powered skin cancer screening device for early detection The company is positioned in the HealthTech sector, serving a growing market with innovative solutions.

Key Information

• Headquarters: Miami, FL
• Founded: 2020
• Team Size: 70+
• Industry: HealthTech

What This Means

This funding round demonstrates strong investor confidence in DermaSensor's vision and execution. The capital will likely be used to:

• Scale Operations: Expand the team and operational capacity
• Product Development: Enhance existing products and develop new features
• Market Expansion: Enter new markets and strengthen presence in existing ones
• Technology Investment: Invest in infrastructure and technology capabilities

Industry Context

The HealthTech sector continues to attract significant investment as companies innovate to meet evolving market demands. DermaSensor's successful fundraising reflects the strong fundamentals and growth potential in this space.

Valuation Milestone

Reaching a $85M valuation marks an important milestone for DermaSensor, positioning the company among notable players in the HealthTech industry.

Looking Ahead

With this new capital, DermaSensor is well-positioned to execute on its growth strategy and continue building innovative solutions in the HealthTech space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.

This fundraising news was reported on 2025-10-06. For more information about DermaSensor, visit their headquarters at Miami, FL.